Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

Market Cap	15.77B -0.8%
Revenue (ttm)	2.66B -6.5%
Net Income	81.24M -52.2%
EPS	0.07 -53.8%
Shares Out	1.12B
PE Ratio	203.29
Forward PE	77.54
Dividend	0.04 (0.25%)
Ex-Dividend Date	Jun 6, 2025

Volume	9,542,024
Average Volume	19,095,647
Open	14.27
Previous Close	14.12
Day's Range	13.65 - 14.27
52-Week Range	13.00 - 21.12
Beta	0.75
RSI	46.82
Earnings Date	Apr 22, 2026

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of human vaccines in China and internationally. The company offers 13-valent pneumococcal polysaccharide conjugate vaccines (TT/DT); varicella vaccines (freeze-dried); hepatitis B vaccines; 23-valent pneumococcal polysaccharide vaccines; diphtheria tetanus acellular pertussis and haemophilus influenzae type B combined vaccines; diphtheria, tetanus, and acellular pertussis combined vaccine, adsorbed; rabies v...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 1,957
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300601

Financial Performance

In 2025, SHE:300601's revenue was 2.67 billion, an increase of 0.81% compared to the previous year's 2.65 billion. Earnings were 70.33 million, a decrease of -65.12%.